Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyBCTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyBCTeam Member asked a question 💭
Pittsburgh, PA

I had 30 rounds of chemo and surgery with lumpectomy and 6 lymph nodes removed 15 days radiation was told cancer free tnbc grade 2 stage 3 was it likely of recurring

December 25, 2025
 · 
Reactions
MyBCTeam

Does a high Ki-67 score of 89 increase recurrence risk for stage 3 grade 2 triple-negative breast cancer after completing treatment?

While Ki-67 is a marker that indicates how quickly cancer cells are dividing, the search results don't specifically address how Ki-67 scores affect recurrence rates in TNBC. However, several Show Full Answer

Does a high Ki-67 score of 89 increase recurrence risk for stage 3 grade 2 triple-negative breast cancer after completing treatment?

While Ki-67 is a marker that indicates how quickly cancer cells are dividing, the search results don't specifically address how Ki-67 scores affect recurrence rates in TNBC. However, several factors related to your situation are relevant.

Stage 3 TNBC does carry a higher recurrence risk. People with stage 3 TNBC are 89 percent more likely to have a recurrence compared to those with earlier stages. Additionally, if cancer has spread to lymph nodes, the risk of relapse more than doubles.

The good news is that you've completed comprehensive treatment including chemotherapy, surgery, lymph node removal, and radiation. Achieving a pathologic complete response (no remaining cancer after treatment) significantly improves outcomes.

For TNBC overall, about 40 percent of people with stage 1-3 disease experience recurrence, with most happening within the first three years. However, if no recurrence occurs within five years, 97 percent remain relapse-free at 10 years.

Your oncology team can best interpret your Ki-67 score in the context of your complete pathology and treatment response. They may recommend closer monitoring during the first few years when recurrence risk is highest.

December 25, 2025

Related Questions

View All
A MyBCTeam Member asked a question 💭
Pittsburgh, PA

A MyBCTeam Member asked a question 💭
Sweden

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In